GlassScriptPhysician profile
Karin H Satra
NPI 1619072303
$6,272.93
in general payments reported to CMS, 2019-2025
25 companies · $1,455 in 2025
The $1,455 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $350 · 2021: $716 · 2022: $1,049 · 2023: $1,429 · 2024: $1,045 · 2025: $1,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,813 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,813.37 |
| Education | $115.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,024.01 | 2021-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $833.07 | 2023-2025 | Tremfya, Simponi Aria, Simponi |
| Novartis Pharmaceuticals Corporation | $708.82 | 2019-2025 | |
| Lilly USA, LLC | $475.68 | 2021-2024 | Olumiant |
| Incyte Corporation | $460.43 | 2022-2023 | Opzelura |
| Sun Pharmaceutical Industries INC. | $309.46 | 2021-2025 | Odomzo, Blu-U |
| Regeneron Healthcare Solutions, INC. | $271.78 | 2020-2025 | Dupixent |
| Genzyme Corporation | $264.67 | 2021-2025 | |
| Pfizer INC. | $250.68 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $245.82 | 2023 | Sotyktu |
| Abbvie INC. | $210.85 | 2022-2025 | |
| Journey Medical Corporation | $140.62 | 2021 | |
| Galderma Laboratories, L.P. | $137.88 | 2019-2025 | Nemluvio |
| Mallinckrodt Hospital Products INC. | $135.36 | 2025 | Acthar |
| Ucb, INC. | $127.04 | 2025 | Bimzelx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $118.74 | 2023 | Poteligeo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $116.14 | 2025 | Cabtreo |
| Janssen Scientific Affairs, LLC | $113.26 | 2020 | |
| Verrica Pharmaceuticals INC. | $106.32 | 2024 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.67 | 2023 | Spevigo |
| Strata Skin Sciences, INC. | $38.29 | 2019-2024 | Xtrac |
| Biofrontera INC. | $29.88 | 2020-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Leo Pharma INC. | $28.44 | 2019-2020 | |
| Allergan, INC. | $15.92 | 2019 | |
| Dermavant Sciences, INC. | $13.10 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Satra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.